Cancer. Malignant neoplasm, primary site unspecified
Conditions
Interventions
Intervention 1: Intervention group: We inject 5 milligram Metadon and 5 milligram Haloperidol in muscular and 10 milligram Diazpam intravenous slowly for 5 minute in first group. Intervention 2: Inter
Sponsors
Vice Chancellor For Research, Arak University Of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with metastatic disease of spine with pain complaints and scurvy of pain 7 and above referring to Emergency hospital of Amiralmomenin and Vali Asr arak Hospital Non-allergic to benzodiazepine and haloperidol
Exclusion criteria
Exclusion criteria: Unsatisfied patients Decreased consciousness at the time of referral or during the study Blood pressure drop of SBP <90 at the time of referral or during the study There is any contraindication in the administration of opioid or Benzodiazepine or Haloperidol Patients with scores of pain less than 7 Oxygen saturation below 92% Heart rate above 90 or under 60
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 1 and 24 hours after intervention. Method of measurement: Visual analog scale.;Patient satisfaction. Timepoint: 24 hours after intervention. Method of measurement: observation.;Side effect of drugs. Timepoint: After intervention. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ramin Parvizrad
Arak University of Medical Sciences
Outcome results
None listed